Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | IT (& TMT) • Medical Devices (& Hospital Services) • Life Science |
Stages | Early Stage, Expansion |
Investing | United Kingdom • Sweden • Denmark |
Investment Range | €500,000 - €10,000,000 |
Assets Under Management | €63,000,000 |
European Equity Partners (EEP) is a venture capital fund with expertise in equity investments within the TMT, life sciences, and medical devices sectors. Their headquarters are strategically located at City Point, 1 Ropemaker Street, in the heart of London, with additional offices in Paris and Stockholm, reflecting their pan-European investment approach. With an impressive assets-under-management figure of €63 million, EEP mainly targets small to mid-market growth businesses with a strong potential for development and expansion. The fund’s investment strategy hinges on the early-stage and expansion phases of innovative companies, with investment sizes ranging from €500,000 to €10,000,000. They provide not just capital, but also strategic support and deep sectorial knowledge thanks to their more than two decades of investment experience. By leveraging an expansive network, EEP aims to identify emerging companies with 'best in class' technology and the ambition to become global leaders in their respective fields. Their investment thesis focuses on building world-class life science companies and devising better medical solutions, thereby contributing to a better world. EEP's approach is one of dedication and commitment—choosing select companies for investment and then engaging with them completely to realize their full potential. Partnership and collaboration are core tenets of their strategy, signifying their belief in working closely with founders and management to achieve mutual success.